Navigation Links
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Date:4/15/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, April 15 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.

This was the second of several regularly scheduled reviews by the DSMB that will occur over the duration of the trial. The purpose of the DSMB is to provide objective, independent safety monitoring of the trial.

To date, more than 65% of the total number of required patients have been enrolled in the Company's MAESTRO-03 clinical trial, with full enrollment anticipated for the end of the first half of 2008.

About MAESTRO-03

----------------

The MAESTRO-03 U.S. pivotal phase III clinical trial is a randomized, double-blind study enrolling approximately 510 patients at more than 60 clinical sites who will be administered either MBP8298 or placebo intravenously every six months for a period of two years. The primary clinical endpoint for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded Disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 positive).

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical to present at BioCentury Conference
2. BioMS Medical Announces 2007 Year End Results
3. BioMS Medical to present at BIO CEO & Investor Conference
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medical announces third quarter 2007 results
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. BioMS Medical to present at BioContact 2007
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)... HOUSTON, July 2 /- Effective immedi...ional levels of Vitamin C (ascorbate) using,its pr...is) technology.,This test enables a clinician to d...long before classic deficiency symptoms appear. Th...has been climbing in recent years and,represents a...
(Date:7/2/2008)... NEW YORK and HAIKOU CITY, China, July 2 /Xinhua-...c. (,China Pharma,) (OTC Bulletin Board:,CPHI) w...nd branded bio-,pharmaceutical products in China, ...t the Collins Stewart Fourth Annual Growth Confere...ference is being held at the Mandarin,Oriental Hot...
(Date:7/2/2008)...Terrence Moore named as Vice President, Marketing ...resident, Corporate Development, PT. RICHMOND, Ca...cals,Inc. today announced the appointment of Terr...eting and Sales and Susan Koppy to the position of...oore and Ms. Koppy will report,to President & Chie...
(Date:7/2/2008)...arvard University and Northeastern University Tech...rcialize Novel Technology for the Extraction of ...ly 2 /- Allied Minds, a pre-seed inve...versity business ventures,Harvard University,s Of...niversity announce the creation of CryoXtract Inst...
Breaking Biology Technology:SpectraCell Laboratories Now Measures Vitamin C 2China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT 2Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2
...to work? There are many ways to assess a workplace...hat inspires the passion of workers and unleashes ... Workers are turned on by what they do and who the...ization for more than the usual reasons - for some...y and generous benefits. While engendering passion...
...n technology suffers from one bugbear above all: c...logy analyst on Wednesday night and explored by pa...Symposium. , ,"Simplicity in IT is something that .... Baird & Co. He said the IT industry is plagued b...ny business processes, too many things to deal wit...
... Harvey said they work together so well because th... The president and CEO of Alliant Energy said ...ef information officers must be "joined at the hip...y,s core business. , ,William Harvey, delivering a...CIO Symposium produced by WTN Media, offered a CE...
... Wisconsin company is presenting at this year,s I...panies from 12 states who will all be working a cr...right connections. , , ZyStor , a firm that was fo...echnology developed in St. Louis, will be there to...isease. The company was drawn to Wisconsin in 2004...
Other Biology Technology:What makes a "best place to work"? 2What makes a "best place to work"? 3What makes a "best place to work"? 4What makes a "best place to work"? 5Simplicity appeals to CIOs, but it's no easy task 2Simplicity appeals to CIOs, but it's no easy task 3CEOs and CIOs must be 'joined at the hip' 2CEOs and CIOs must be 'joined at the hip' 3Lone Wisconsin firm to present at InvestMidwest 2
(Date:7/3/2008)...o slow the signs of aging and live longer? New Sai... on calories could be a promising strategy. , C... aging process in rats and mice. While scientists ...ing process in rodents, one popular hypothesis is ...e, triiodothyronine (T3), which then slows metabol...
(Date:7/2/2008).... July 2, 2008 Standing in a greenhouse at the U...ng even though it appeared that something had gone...grass she planted last February in hundreds of sma... turf science wasn,t surprised. That,s because th...ter for five months, and few varieties of grass ca...
(Date:7/2/2008)...r of a worldwide outbreak of avian or "bird flu" l...are desperately needed since some strains of the v...ent roster of anti-flu remedies. , Now, a team o...rces at the San Diego Supercomputer Center (SDSC),...o dozen promising and novel compounds from which n...
(Date:7/2/2008)...rth Carolina State University have found that quan...ere is an abrasion, providing insight into potenti...dividuals involved in the manufacturing of quantum...plications of the tiny nanoparticles. , While t...s, shapes and surface coatings do not penetrate ra...
Breaking Biology News(10 mins):Looking for the Founatain of Youth? Cut your calories, research suggests 2Search for salt tolerant grasses aims to improve roadside plantings 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Study shows quantum dots can penetrate skin through minor abrasions 2The Healthplace America 28TM 29 Benefit Delivers a Better Option in Healthcare 14296 1The Healthplace America 28TM 29 Benefit Delivers a Better Option in Healthcare 14296 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 2Men are Opting to Remove Spider Veins Over Replacing Hair 14288 1Men are Opting to Remove Spider Veins Over Replacing Hair 14288 2Prescription costs rise more than 6 times when patients reach 65 says study of 5M people 14285 1Prescription costs rise more than 6 times when patients reach 65 says study of 5M people 14285 2
...paleobiologist J. William Schopf and colleagues ha...illion to 850 million years old -- preserved in ro...e. , If a future space mission to Mars brings rock... used, called confocal laser scanning microscopy a...look at microscopic fossils inside the rocks to se...
...action by an alliance of conservation groups battl...s most important sites for endangered species. , A...national (CI), and Fundación ProAves of Colombia s...rthwest slope of the Sierra Nevada de Santa Marta ... its development for vacation homes. , The site i...
... UCLA imaging study shows that age-related breakdo...in,s internal wiring, correlates strongly with the...er disease. , The findings are detailed in the Jan... of General Psychiatry and add to a growing body o...tor to the onset of Alzheimer disease later in lif...
...protein was previously thought to play a role sole...rial infection. In the new study, which will be pu... Academy of Sciences of the United States of Ameri... time that the protein, which is present in epithe...inked to the control of malignant cell growth. , T...
Other Biology News:Inside rocks, implications for finding life on Mars 2Crucial site for endangered frogs and birds saved 2Imaging study links key genetic risk for Alzheimer's disease to myelin breakdown 2Protein found to control tumor growth in certain breast cancers 2
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed
...e/PAD: ZMD.414. Immunogen: Synthetic peptide deri... mTOR (Mammalian target of rapamycin FRAP RAFT1 RA...otein. On Western blots it identifies the target ...trol: HEK293 cell lysates). Based on sequence homo...
Fok I from Promega
From micro to giga sizes, from single prep to high-throughput, Invitrogen's range of plasmid purification kits offers superior performance to match the demands of your downstream application.
Biology Products: